DUBLIN , Feb. 16, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced the publication of a new manuscript presenting real-world evidence on treatment patterns for patients with plantar fibromatosis....
DUBLIN , Jan. 21, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that it reached a milestone: 100,000 patients with Peyronie's disease (PD) have been prescribed XIAFLEX ®...
Analysis to Be Presented at the American Association for Hand Surgery Meeting
DUBLIN , Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London...
Delivers Third Quarter Net Sales of $753.1 Million, Driven by Acthar ® Gel (repository corticotropin injection) Growth and the Inclusion of Two Months of Endo Product Net Sales
Keenova Focused on Advancing Therapies to Address Unmet Patient NeedsÂ
– Four poster presentations, including one AASLD Poster of Distinction, will highlight research in hepatorenal syndrome –
DUBLIN , Oct. 23, 2025 /PRNewswire/ -- Mallinckrodt plc , a global specialty pharmaceutical company, announced today that it will report its third quarter 2025 financial results on Monday, November...
– HRS Awareness Day will be observed annually on October 14 during National Liver Awareness Month, with the goal of raising awareness around a life-threatening condition that occurs in people with advanced...
– Cross-sectional physician survey and medical chart review showed some patients evaluated with AS or PsA who were treated with Acthar Gel experienced a reported reduction in overall symptoms, decreased...